Bryan Wahl is General Counsel of Tarsus Pharmaceuticals, Inc.. Currently has a direct ownership of 40,951 shares of TARS, which is worth approximately $2.25 Million. The most recent transaction as insider was on Mar 18, 2024, when has been sold 4,436 shares (Common Stock) at a price of $30.6 per share, resulting in proceeds of $135,741. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 41K
0% 3M change
28.11% 12M change
Total Value Held $2.25 Million

Bryan Wahl Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 18 2024
SELL
Open market or private sale
$135,741 $30.6 p/Share
4,436 Reduced 9.77%
40,951 Common Stock
Mar 15 2024
BUY
Exercise of conversion of derivative security
-
12,038 Added 20.96%
45,387 Common Stock
Nov 30 2023
SELL
Open market or private sale
$136,286 $16.31 p/Share
8,356 Reduced 20.72%
31,966 Common Stock
Nov 29 2023
BUY
Exercise of conversion of derivative security
-
23,920 Added 37.23%
40,322 Common Stock
Mar 23 2023
SELL
Open market or private sale
$4,507 $12.15 p/Share
371 Reduced 2.21%
16,402 Common Stock
Mar 22 2023
SELL
Open market or private sale
$4,512 $12.64 p/Share
357 Reduced 2.08%
16,773 Common Stock
Mar 21 2023
SELL
Open market or private sale
$4,511 $12.89 p/Share
350 Reduced 2.0%
17,130 Common Stock
Mar 20 2023
SELL
Open market or private sale
$4,501 $12.61 p/Share
357 Reduced 2.0%
17,480 Common Stock
Mar 17 2023
SELL
Open market or private sale
$4,501 $13.28 p/Share
339 Reduced 1.87%
17,837 Common Stock
Mar 16 2023
SELL
Open market or private sale
$4,525 $13.43 p/Share
337 Reduced 1.82%
18,176 Common Stock
Mar 15 2023
BUY
Exercise of conversion of derivative security
-
4,790 Added 20.56%
18,513 Common Stock
Dec 02 2022
SELL
Open market or private sale
$19,502 $16.9 p/Share
1,154 Reduced 7.76%
13,723 Common Stock
Dec 01 2022
SELL
Open market or private sale
$19,497 $16.75 p/Share
1,164 Reduced 7.26%
14,877 Common Stock
Nov 30 2022
SELL
Open market or private sale
$19,519 $16.5 p/Share
1,183 Reduced 6.87%
16,041 Common Stock
Nov 29 2022
BUY
Exercise of conversion of derivative security
-
10,251 Added 37.31%
17,224 Common Stock
BW

Bryan Wahl

General Counsel
Irvine, CA

Track Institutional and Insider Activities on TARS

Follow Tarsus Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells TARS shares.

Notify only if

Insider Trading

Get notified when an Tarsus Pharmaceuticals, Inc. insider buys or sells TARS shares.

Notify only if

News

Receive news related to Tarsus Pharmaceuticals, Inc.

Track Activities on TARS